“PO-78 | No Changes in Blood Pressure Assessed With the 24-Hour Holter Monitoring in Patients Treated With Anti-CGRP Monoclonal Antibodies: A Prospective Observational Study (SAFHYPER): Flavia Lo Castro,1 Niccolò Bonini,2 Luigi Francesco Iannone,1,3 Alberto Boccalini,1 Daria Brovia,1 Luca Pani,1,3 Giuseppe Boriani,2,3 Simona Guerzoni1 | 1Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, Modena, Italy; 2Cardiology Division, AOU Policlinico Di Modena, Modena, Italy; 3Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, Italy”. 2025. Confinia Cephalalgica 35 (S1). https://doi.org/10.4081/cc.2025.15902.